GlySens raises $20M Series D for its ICGM system
The company's ICGM system has an intended one-year life, and can wirelessly link to an external receiver to provide glucose measurement, recording and alerts.
GlySens raises $12M Series C for its continuous glucose monitoring system
The new capital will go towards development of its the company's ICGM continuous glucose monitoring system for people with diabetes.